Pre-Open Stock Movers 07/07: (DARE) (OPNT) (BHVN) Higher; (BSQR) (IDYA) (LOAN) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
SMART Global Holdings, Inc. (SGH) Announces Proposed 3M Share Offering
July 8, 2021 5:49 PM EDTSMART Global Holdings, Inc. (SGH or the Company) (Nasdaq: SGH) today announced the launch of a proposed underwritten public offering of 3,000,000 of its ordinary shares by certain selling shareholders affiliated with Silver Lake (the Selling Shareholders). The Company is not selling any of its ordinary shares in the offering and will not receive any of the proceeds from the sale of its... More
Biohaven Pharmaceuticals (BHVN) Gains Following Sales Surge for Migraine Drug NURTEC ODT
July 7, 2021 11:36 AM EDTBiohaven Pharmaceutical (NYSE: BHVN) shares are gaining 11% following the announcement of preliminary Q2 results: net product revenue of NURTEC ODT (rimegepant) came in at $93M, increasing 119% Q/Q. Total prescriptions since the product launch exceeded 750,000 across 38,000 unique subscribers.
The results have far outpaced analysts' expectations consensus sales figures hovered around $50-55 million.
Commenting on the strong performance, the companys CCO, BJ... More
